{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-167884","form_type":"8-K","ticker":"BMEA","cik":"0001840439","company_name":"Biomea Fusion, Inc.","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.076488+00:00","generated_at":"2026-06-14T00:35:27.579000+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Biomea Fusion shareholders elect two Class II directors and ratify Deloitte as auditor","bullets":["Class II directors elected: Rainer Erdtmann (16,369,686 for, 5,798,793 withheld) and Eric Aguiar, M.D. (16,248,905 for, 5,919,574 withheld); 4,235,582 broker non-votes.","Ratification of Deloitte & Touche as independent auditor for FY 2023 approved with 26,375,250 for, 7,575 against, 21,236 abstentions; no broker non-votes.","Total shares entitled to vote: 35,648,288; shares present or proxy: 26,404,061."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-167884","json":"https://secwatch.observer/filing/0001193125-23-167884.json","markdown":"https://secwatch.observer/filing/0001193125-23-167884.md","text":"https://secwatch.observer/filing/0001193125-23-167884.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840439/000119312523167884/0001193125-23-167884-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840439/000119312523167884/d516349d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T00:35:27.579000+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ad58cf608e38eae5dd206fd32269f42597fdd9ca","claim":"Biomea Fusion, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm at the 2023-06-14 meeting.","evidence_excerpt":"Proposal 2 - Ratification of Appointment of Independent Registered Accounting Firm The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023. Votes For Votes Against Abstentions 26,375,250 7,575 21,236 There were zero broker non-votes regarding this proposal.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840439/000119312523167884/0001193125-23-167884-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"},{"claim_id":"f0ded35193952a6e4c52f9ab7329f3184f2c55d4","claim":"Biomea Fusion, Inc. shareholders approved Election of two Class II directors at the 2023-06-14 meeting.","evidence_excerpt":"Proposal 1 - Election of Directors The Company’s stockholders elected the two (2) director nominees below to the Company’s Board of Directors as Class II directors to hold office until the 2026 Annual Meeting of Stockholders of the Company or until their successors are duly elected and qualified. Director Nominee Votes For Votes Withheld Rainer (Ramses) Erdtmann 16,369,686 5,798,793 Eric Aguiar, M.D. 16,248,905 5,919,574 There were 4,235,582 broker non-votes regarding this proposal.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840439/000119312523167884/0001193125-23-167884-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}